Lung cancer
Conditions
Interventions
None listed
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Patients with confirmed or suspected non-small cell lung cancer • Signed informed consent • Adult (>= 18 years of age) and mentally competent
Exclusion criteria
Exclusion criteria: • Patients with a benign lesion • Patients with a metastasis of another primary cancer than lung cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim of this study is to implement the ctDNA analysis to identify actionable targets in lung tumors. We envision this study will create awareness in regional hospitals with this novel test method. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Percentage of patients identified as having an activating and targetable genetic alteration as determined by tissue and liquid biopsies with an intra-individual comparison of the presence of driver mutations detected in tissue and liquid biopsies. 2. To get insight in the time it takes from diangosis to start of targeted treatment. 3. The percentage of patient with inadequate tissue for analysis where ctDNA may be an alternative. 4. Exploring cost- effectiveness | — |
Countries
Netherlands
Outcome results
None listed